BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced an exploratory research collaboration to create antibody-drug con...

December 14, 2022 | News

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. Lilly unites caring with ...

December 13, 2022 | News

Exact Sciences to Advance Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for it...

December 12, 2022 | News

Research Highlights Cutting-Edge New Treatments for Blood Disorders

New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches for several ...

December 12, 2022 | News

10x Genomics Commercially Launches Xenium Platform for In Situ Analysis

10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first co...

December 09, 2022 | News

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group couple...

December 08, 2022 | News

Sartorius agrees with BICO on strategic cooperation as well as a 10 percent capital investment

BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...

December 08, 2022 | News

FDA grants ODD for new NK treatment

The US FDA has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye diseas...

December 08, 2022 | News

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...

December 07, 2022 | News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...

December 02, 2022 | News

1 December is World AIDS Day 2022 | Equalize

The day is an opportunity for public and private partners to spread awareness about the status of the pandemic and encourage progress in HIV/AIDS preventio...

December 01, 2022 | News

GE Healthcare Introduces SIGNA Experience

GE Healthcare announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey. T...

November 28, 2022 | News

GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

Drawing on more than 100 years of history as a trusted medical technology innovator1, GE Healthcare is closely connected with healthcare systems globally. ...

November 28, 2022 | News

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver more Medicines to Patients Faster

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...

November 23, 2022 | News

Stay Connected